The FDA’s Vaccines and Related Biological Products Advisory Committee today voted 9-0 to recommend approval of Moderna’s mRNA flu vaccine for the 50-64 and 65-plus age groups. Karl Jablonowski, Ph.D., senior research scientist for Children’s Health Defense, said, “The unanimous vote guarantees a lot of really good questions of harm […]
The post Breaking: Moderna’s mRNA Flu Vaccine Gets Unanimous Thumbs-Up Despite Risks, Low Efficacy appeared first on Activist Post.
